This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 181 
1 out of 64 
Years Active: 2026
Title: Silke Weber: Innovator in Synucleinopathies Treatment
Introduction
Silke Weber is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. Her innovative work has led to the development of a patent that addresses critical aspects of this complex condition.
Latest Patents
Silke Weber holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents her commitment to advancing therapeutic strategies for diseases associated with abnormal protein aggregation, which are crucial for improving patient outcomes.
Career Highlights
Throughout her career, Silke has worked with notable companies, including F. Hoffmann-La Roche AG and Prothena Biosciences Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the pharmaceutical industry, enhancing her expertise in drug development and innovation.
Collaborations
Silke has collaborated with talented individuals such as Jay Soto and Daniel Keith Ness. These partnerships have fostered a dynamic exchange of ideas and have contributed to her success in the field.
Conclusion
Silke Weber's contributions to the treatment of synucleinopathies through her innovative patent and collaborations with industry leaders highlight her role as a key figure in medical research. Her work continues to inspire advancements in therapeutic approaches for complex neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile